Inhibition of sodium- and potassium-dependent adenosine triphosphatase by ethacrynic acid: ligand-induced modifications.
D000231:Adenocarcinoma, Papillary / Q000037:antagonists & inhibitors*; D000244:Adenosine Diphosphate; D000249:Adenosine Monophosphate; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000255:Adenosine Triphosphate; D000494:Allosteric Regulation; D000641:Ammonia / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D001692:Biological Transport; D002384:Catalysis; D002586:Cesium / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D004789:Enzyme Activation; D004976:Ethacrynic Acid / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007668:Kidney / Q000166:cytology / Q000201:enzymology*; D007700:Kinetics; D008024:Ligands; D008274:Magnesium; D008861:Microsomes / Q000201:enzymology; D008954:Models, Biological; D008968:Molecular Conformation; D009711:Nucleotides / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010710:Phosphates; D010758:Phosphorus / Q000378:metabolism; D010759:Phosphorus Isotopes; D010761:Phosphorus Radioisotopes; D011188:Potassium; D011485:Protein Binding; D011487:Protein Conformation; D000644:Quaternary Ammonium Compounds; D012413:Rubidium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013997:Time Factors
D008024:Ligands; D009711:Nucleotides; D010710:Phosphates; D010759:Phosphorus Isotopes; D010761:Phosphorus Radioisotopes; D000644:Quaternary Ammonium Compounds; D002586:Cesium; D010758:Phosphorus; D000249:Adenosine Monophosphate; D010042:Ouabain; D000244:Adenosine Diphosphate; D000641:Ammonia; D000255:Adenosine Triphosphate; D012964:Sodium; D000251:Adenosine Triphosphatases; D008274:Magnesium; D004976:Ethacrynic Acid; D012413:Rubidium; D011188:Potassium